SCNI

#5161
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.6021 USD
+1.81%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.6021
0.6021
Year Range
0.5500
1.0499
Daily Change
+1.81%
Monthly Change
-13.89%
6 month change
-20.38%
Year Change
-20.38%
Previous Close
0.5914
Open
0.6021
Bid
Ask
Low
0.6021
High
0.6021
Volume
1
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 2.0882 M
  • Employee 45
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Biotechnology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

News